| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-33180 | |||
| IHC-Prediluted | NBP2-45173 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-45179 | |||
| Azide and BSA Free | NBP2-34558-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-45174 | |||
| Azide and BSA Free | NBP2-34741-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-33128 | |||
| IHC-Prediluted | NBP2-45175 | |||
| Azide and BSA Free | NBP2-33128-1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-45177 | |||
| Azide and BSA Free | NBP2-34591-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-45176 | |||
| Azide and BSA Free | NBP2-34783-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-09037-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-09038-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52672-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-45178 | |||
| Azide and BSA Free | NBP2-34557-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-45178 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-08565 | |||
![Immunohistochemistry-Paraffin: TAG-72 Antibody (B72.3) [NBP2-29412] - Analysis using the Azide and BSA Free version of NBP2-29412. Staining of human Prostate Carcinoma stained with TAG-72 MAb (B72.3).](http://images.novusbio.com/fullsize/TAG-72-Antibody-B72-3-Immunohistochemistry-Paraffin-NBP2-29412-img0007.jpg "Immunohistochemistry-Paraffin: TAG-72 Antibody (B72.3) [NBP2-29412] - Analysis using the Azide and BSA Free version of NBP2-29412. Staining of human Prostate Carcinoma stained with TAG-72 MAb (B72.3).")
![Immunohistochemistry-Paraffin: TAG-72 Antibody (B72.3) [NBP2-29412] - Analysis using the Azide and BSA Free version of NBP2-29412. Staining of human Colon Carcinoma stained with TAG-72 MAb (B72.3).](http://images.novusbio.com/fullsize/TAG-72-Antibody-B72-3-Immunohistochemistry-Paraffin-NBP2-29412-img0005.jpg)
![Immunohistochemistry-Paraffin: TAG-72 Antibody (B72.3) [NBP2-29412] - Analysis using the Azide and BSA Free version of NBP2-29412. Staining of human Ovarian Carcinoma stained with TAG-72 MAb (B72.3).](http://images.novusbio.com/fullsize/TAG-72-Antibody-B72-3-Immunohistochemistry-Paraffin-NBP2-29412-img0006.jpg)
![Immunohistochemistry-Paraffin: TAG-72 Antibody (B72.3 + CC49) [NBP2-34242] - Analysis using the Azide and BSA Free version of NBP2-34242. Staining of human Prostate Carcinoma stained with TAG-72 MAb (B72.3 + CC49).](http://images.novusbio.com/fullsize/TAG-72-Antibody-B72-3-+-CC49-Immunohistochemistry-Paraffin-NBP2-34242-img0003.jpg "Immunohistochemistry-Paraffin: TAG-72 Antibody (B72.3 + CC49) [NBP2-34242] - Analysis using the Azide and BSA Free version of NBP2-34242. Staining of human Prostate Carcinoma stained with TAG-72 MAb (B72.3 + CC49).")
![Immunohistochemistry-Paraffin: TAG-72 Antibody (B72.3 + CC49) [NBP2-34242] - Analysis using the Azide and BSA Free version of NBP2-34242. Staining of human Ovarian Carcinoma stained with TAG-72 MAb (B72.3 + CC49).](http://images.novusbio.com/fullsize/TAG-72-Antibody-B72-3-+-CC49-Immunohistochemistry-Paraffin-NBP2-34242-img0002.jpg)
![Immunohistochemistry-Paraffin: TAG-72 Antibody (SPM148) [NBP2-32995] - Formalin-paraffin colon cancer stained with TAG-72 MAb (SPM148). Note cytoplasmic and cell surface staining.](http://images.novusbio.com/fullsize/TAG-72-Antibody-SPM148-Immunohistochemistry-Paraffin-NBP2-32995-img0001.jpg "Immunohistochemistry-Paraffin: TAG-72 Antibody (SPM148) [NBP2-32995] - Formalin-paraffin colon cancer stained with TAG-72 MAb (SPM148). Note cytoplasmic and cell surface staining.")
![Immunohistochemistry-Paraffin: TAG-72 Antibody (CC49) [NBP2-31383] - Analysis using the Azide and BSA Free version of NBP2-31383. Staining of human Prostate Carcinoma stained with TAG-72 MAb (CC49).](http://images.novusbio.com/fullsize/TAG-72-Antibody-CC49-Immunohistochemistry-Paraffin-NBP2-31383-img0009.jpg "Immunohistochemistry-Paraffin: TAG-72 Antibody (CC49) [NBP2-31383] - Analysis using the Azide and BSA Free version of NBP2-31383. Staining of human Prostate Carcinoma stained with TAG-72 MAb (CC49).")
![Immunohistochemistry-Paraffin: TAG-72 Antibody (CC49) [NBP2-31383] - Analysis using the Azide and BSA Free version of NBP2-31383. Staining of human Ovarian Carcinoma stained with TAG-72 MAb (CC49).](http://images.novusbio.com/fullsize/TAG-72-Antibody-CC49-Immunohistochemistry-Paraffin-NBP2-31383-img0008.jpg)
![Immunohistochemistry-Paraffin: TAG-72 Antibody (CA72/733) [NBP2-32903] - Formalin-fixed, paraffin-embedded human colon cancer stained with TAG-72 MAb (CA72/733), using HRPO-DAB. Note cytoplasmic and cell surface staining.](http://images.novusbio.com/fullsize/TAG-72-Antibody-CA72-733-Immunohistochemistry-Paraffin-NBP2-32903-img0001.jpg "Immunohistochemistry-Paraffin: TAG-72 Antibody (CA72/733) [NBP2-32903] - Formalin-fixed, paraffin-embedded human colon cancer stained with TAG-72 MAb (CA72/733), using HRPO-DAB. Note cytoplasmic and cell surface staining.")
![Immunohistochemistry-Paraffin: TAG-72 Antibody (CA72/733) [NBP2-32903] - Formalin-fixed, paraffin-embedded human prostate carcinoma stained with TAG-72 Monoclonal Antibody (CA72/733).](http://images.novusbio.com/fullsize/TAG-72-Antibody-CA72-733-Immunohistochemistry-Paraffin-NBP2-32903-img0002.jpg)
![Immunohistochemistry-Paraffin: TAG-72 Antibody (CA72/733) [NBP2-32903] - Formalin-fixed paraffin-embedded human ovarian carcinoma stained with TAG-72 Monoclonal Antibody (CA72/733).](http://images.novusbio.com/fullsize/TAG-72-Antibody-CA72-733-Immunohistochemistry-Paraffin-NBP2-32903-img0004.jpg)
![Immunohistochemistry-Paraffin: TAG-72 Antibody (SPM536) [NBP2-32996] - Formalin-paraffin colon cancer stained with TAG-72 MAb (SPM536). Note cytoplasmic and cell surface staining.](http://images.novusbio.com/fullsize/TAG-72-Antibody-SPM536-Immunohistochemistry-Paraffin-NBP2-32996-img0001.jpg "Immunohistochemistry-Paraffin: TAG-72 Antibody (SPM536) [NBP2-32996] - Formalin-paraffin colon cancer stained with TAG-72 MAb (SPM536). Note cytoplasmic and cell surface staining.")
![Immunocytochemistry/Immunofluorescence: TAG-72 Antibody (Minretumomab (CC49)) [NBP3-09037] - Immunofluorescence analysis of paraformaldehyde fixed Jurkat cells stained with the chimeric mouse IgG version of Minretumomab (CC49 ) (NBP3-09037) at 10 ug/ml followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-09037, DAPI, merged channels and an isotype control. The isotype control was stained with anti-unknown antibody followed by Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/TAG-72-Antibody-Minretumomab-CC49-Immunocytochemistry-Immunofluorescence-NBP3-09037-img0002.jpg "Immunocytochemistry/Immunofluorescence: TAG-72 Antibody (Minretumomab (CC49)) [NBP3-09037] - Immunofluorescence analysis of paraformaldehyde fixed Jurkat cells stained with the chimeric mouse IgG version of Minretumomab (CC49 ) (NBP3-09037) at 10 ug/ml followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-09037, DAPI, merged channels and an isotype control. The isotype control was stained with anti-unknown antibody followed by Alexa Fluor(R) 488 secondary antibody.")
![Flow Cytometry: TAG-72 Antibody (Minretumomab (CC49)) [NBP3-09037] - Jurkat cells were stained with anti-unknown IgG antibody (Ab; isotype control, black line) or the mouse IgG-chimeric version of Minretumomab (CC49 ) (NBP3-09037, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/TAG-72-Antibody-Minretumomab-CC49-Flow-Cytometry-NBP3-09037-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: TAG-72 Antibody (Minretumomab (CC49)) - Chimeric [NBP3-09038] - Immunofluorescence analysis of paraformaldehyde fixed Jurkat cells immobilized on Shi-fix(TM) cover-slips and stained with the chimeric rabbit IgG version of Minretumomab (CC49) (NBP3-09038) at 10 ug/ml followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing strong membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-09038, DAPI, merged channels and an isotype control. The isotype control was stained with anti-Fluorescein antibody followed by Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/TAG-72-Antibody-Minretumomab-CC49-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-09038-img0002.jpg "Immunocytochemistry/Immunofluorescence: TAG-72 Antibody (Minretumomab (CC49)) - Chimeric [NBP3-09038] - Immunofluorescence analysis of paraformaldehyde fixed Jurkat cells immobilized on Shi-fix(TM) cover-slips and stained with the chimeric rabbit IgG version of Minretumomab (CC49) (NBP3-09038) at 10 ug/ml followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing strong membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-09038, DAPI, merged channels and an isotype control. The isotype control was stained with anti-Fluorescein antibody followed by Alexa Fluor(R) 488 secondary antibody.")
![Flow Cytometry: TAG-72 Antibody (Minretumomab (CC49)) - Chimeric [NBP3-09038] - Jurkat cells were stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG1 version of Minretumomab (CC49 ) (NBP3-09038, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/TAG-72-Antibody-Minretumomab-CC49-Chimeric-Flow-Cytometry-NBP3-09038-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: TAG-72 Antibody (B72.3 (Satumomab)) [NBP2-52672] - Staining of formaldehyde-fixed human rectal carcinoma slices were stained at 5 ug/ml and detected with a Cy3-conjugated secondary antibody.](http://images.novusbio.com/fullsize/TAG-72-Antibody-B72-3-Satumomab-Immunocytochemistry-Immunofluorescence-NBP2-52672-img0001.jpg "Immunocytochemistry/Immunofluorescence: TAG-72 Antibody (B72.3 (Satumomab)) [NBP2-52672] - Staining of formaldehyde-fixed human rectal carcinoma slices were stained at 5 ug/ml and detected with a Cy3-conjugated secondary antibody.")
![Immunohistochemistry: TAG-72 Antibody (B72.3 (Satumomab)) [NBP2-52672] - Staining of formalin fixed human ovarian cancer slices were were stained with a Ab00280-1.1 at 5 ug/ml.](http://images.novusbio.com/fullsize/TAG-72-Antibody-B72-3-Satumomab-Immunohistochemistry-NBP2-52672-img0003.jpg)
![Immunohistochemistry: TAG-72 Antibody (B72.3 (Satumomab)) [NBP2-52672] - Staining of formalin fixed human rectal carcinoma slices were were stained with a Ab00280-1.1 at 5 ug/ml.](http://images.novusbio.com/fullsize/TAG-72-Antibody-B72-3-Satumomab-Immunohistochemistry-NBP2-52672-img0002.jpg)
![Immunohistochemistry-Paraffin: TAG-72 Antibody (B72.3 + CA72/733) [NBP2-34241] - Formalin-fixed, Paraffin-embedded human ovarian carcinoma stained with TAG-72 Monoclonal Antibody (B72.3+CA72/733)](http://images.novusbio.com/fullsize/TAG-72-Antibody-B72-3-+-CA72-733-Immunohistochemistry-Paraffin-NBP2-34241-img0003.jpg "Immunohistochemistry-Paraffin: TAG-72 Antibody (B72.3 + CA72/733) [NBP2-34241] - Formalin-fixed, Paraffin-embedded human ovarian carcinoma stained with TAG-72 Monoclonal Antibody (B72.3+CA72/733)")
![Immunohistochemistry-Paraffin: TAG-72 Antibody (B72.3 + CA72/733) [NBP2-34241] - Formalin-fixed. paraffin-embedded human Prostate carcinoma stained with TAG-72 Monoclonal Antibody (B72.3+CA72/733)](http://images.novusbio.com/fullsize/TAG-72-Antibody-B72-3-+-CA72-733-Immunohistochemistry-Paraffin-NBP2-34241-img0002.jpg)
![Immunohistochemistry-Paraffin: TAG-72 Antibody (B72.3 + CA72/733) - Azide and BSA Free [NBP2-34557] - Formalin-fixed, Paraffin-embedded human ovarian carcinoma stained with TAG-72 Monoclonal Antibody (B72.3+CA72/733)](http://images.novusbio.com/fullsize/TAG-72-Antibody-B72-3-+-CA72-733-Azide-and-BSA-Free-Immunohistochemistry-Paraffin-NBP2-34557-img0002.jpg "Immunohistochemistry-Paraffin: TAG-72 Antibody (B72.3 + CA72/733) - Azide and BSA Free [NBP2-34557] - Formalin-fixed, Paraffin-embedded human ovarian carcinoma stained with TAG-72 Monoclonal Antibody (B72.3+CA72/733)")
![Immunohistochemistry-Paraffin: TAG-72 Antibody (B72.3 + CA72/733) - Azide and BSA Free [NBP2-34557] - Formalin-fixed. paraffin-embedded human Prostate carcinoma stained with TAG-72 Monoclonal Antibody (B72.3+CA72/733)](http://images.novusbio.com/fullsize/TAG-72-Antibody-B72-3-+-CA72-733-Azide-and-BSA-Free-Immunohistochemistry-Paraffin-NBP2-34557-img0001.jpg)
![Immunohistochemistry-Paraffin: TAG-72 Antibody (rB72.3) [NBP3-07685] - Formalin-fixed, paraffin-embedded human Breast Carcinoma stained with TAG-72 Recombinant Mouse Monoclonal Antibody (rB72.3).](http://images.novusbio.com/fullsize/TAG-72-Antibody-rB72-3-Immunohistochemistry-Paraffin-NBP3-07685-img0001.jpg "Immunohistochemistry-Paraffin: TAG-72 Antibody (rB72.3) [NBP3-07685] - Formalin-fixed, paraffin-embedded human Breast Carcinoma stained with TAG-72 Recombinant Mouse Monoclonal Antibody (rB72.3).")